Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma studyLeila Khoja, Anthony M. Joshua, Takami Sato et al.|Annals of Oncology|2019Cited by 282
Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II studyF. Mouriaux, Florence Joly, Vincent Servois et al.|British Journal of Cancer|2016Cited by 48